Skip to main navigation Skip to search Skip to main content

Panuveitis unter Dabrafenib/Trametinib-Therapie bei malignem kutanem Melanom persistierend nach Therapieende

Translated title of the contribution: Panuveitis under dabrafenib/trametinib treatment for malignant cutaneous melanoma persisting after completion of treatment

Research output: Contribution to journalCommunication

2 Citations (Web of Science)
Translated title of the contributionPanuveitis under dabrafenib/trametinib treatment for malignant cutaneous melanoma persisting after completion of treatment
Original languageGerman (Austria)
Pages (from-to)842-844
Number of pages3
JournalDie Ophthalmologie
Volume121
Issue number10
Early online dateSept 2024
DOIs
Publication statusPublished - Oct 2024

Branches of science

  • 301 Medical-Theoretical Sciences, Pharmacy
  • 302 Clinical Medicine
  • 303 Health Sciences
  • 305 Other Human Medicine, Health Sciences

Cite this